Lab
Laboratorio Clinico Y De Ref De Fajardo INC
Laboratorio Clinico Y De Ref De Fajardo INC was paid $2.78M by Medicaid between Jan 2018 and Dec 2024, across 138 billing codes. Its largest line is G2023, Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source — 12% of everything it billed.
33Billing provider infoLABORATORIO CLINICO Y DE REF DE FAJARDO INC
FAJARDO, PR 00738
FAJARDO, PR 00738
33aNPI1689724866assigned 01/11/2007
33bProvider typeClinical Medical Laboratory
28Total paid$2.78M
24GClaims821,279
24DCodes billed138
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#27 of 777
Median peer was paid$278K
This provider vs. median10.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 93,744 | $181K | |
| 2019 | 89,333 | $282K | |
| 2020 | 96,895 | $340K | |
| 2021 | 133,075 | $601K | |
| 2022 | 124,943 | $461K | |
| 2023 | 157,887 | $461K | |
| 2024incomplete | 125,402 | $450K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 12% | 32,175 | 27,801 | $331K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 11% | 16,714 | 14,814 | $307K |
| 84443 | Thyroid stimulating hormone (TSH) | 7.1% | 51,221 | 47,717 | $196K |
| 80061 | Lipid panel | 7.0% | 61,234 | 57,504 | $195K |
| 80053 | Comprehensive metabolic panel | 5.0% | 58,821 | 54,338 | $139K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 4.4% | 17,876 | 15,494 | $121K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.3% | 75,748 | 67,982 | $118K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.1% | 5,249 | 4,743 | $113K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.3% | 32,272 | 14,544 | $92K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.9% | 11,489 | 10,650 | $80K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.7% | 11,504 | 10,495 | $76K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.7% | 11,415 | 10,417 | $76K |
126 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | 2.7% | 31,128 | $75K |
| 87536 | 2.5% | 1,535 | $69K | |
| 81001 | 2.0% | 77,926 | $55K | |
| 80074 | 1.6% | 3,337 | $45K | |
| 86328 | 1.6% | 5,086 | $44K | |
| 85027 | 1.6% | 21,632 | $43K | |
| 82274 | 1.5% | 13,135 | $41K | |
| 84153 | 1.4% | 9,178 | $38K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.3% | 15,737 | $37K |
| 86703 | 1.2% | 11,185 | $32K | |
| 86738 | 1.0% | 11,969 | $28K | |
| 84439 | <1% | 12,816 | $27K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 816 | $24K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 10,519 | $21K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,522 | $20K |
| 82043 | <1% | 18,385 | $20K | |
| 80050 | General health panel | <1% | 19,109 | $18K |
| 86361 | <1% | 1,356 | $18K | |
| 84436 | <1% | 8,500 | $15K | |
| 82607 | <1% | 4,797 | $14K | |
| 84479 | <1% | 9,516 | $14K | |
| 86803 | <1% | 3,701 | $13K | |
| 86592 | <1% | 14,446 | $13K | |
| 85730 | <1% | 8,288 | $10K | |
| 82570 | <1% | 8,153 | $9K | |
| 86038 | <1% | 3,317 | $8K | |
| 85610 | <1% | 8,479 | $7K | |
| 87340 | <1% | 3,374 | $7K | |
| 82728 | <1% | 2,223 | $7K | |
| 87177 | <1% | 2,829 | $7K | |
| 85651 | <1% | 8,027 | $6K | |
| 84703 | <1% | 3,564 | $6K | |
| 84156 | <1% | 6,937 | $6K | |
| 83655 | <1% | 3,571 | $5K | |
| 83970 | <1% | 424 | $5K | |
| 82951 | <1% | 1,806 | $5K | |
| 84702 | <1% | 1,287 | $5K | |
| 84146 | <1% | 803 | $5K | |
| 82746 | <1% | 1,457 | $4K | |
| 86762 | <1% | 1,065 | $4K | |
| 87070 | <1% | 2,223 | $4K | |
| 82378 | <1% | 767 | $4K | |
| 83001 | <1% | 669 | $4K | |
| 86140 | <1% | 3,224 | $4K | |
| 82950 | <1% | 3,086 | $4K | |
| 86701 | <1% | 2,527 | $3K | |
| 82105 | <1% | 837 | $3K | |
| 82677 | <1% | 549 | $3K | |
| 83540 | <1% | 2,469 | $3K | |
| 84550 | <1% | 2,842 | $3K | |
| 86696 | <1% | 590 | $3K | |
| 87077 | <1% | 1,633 | $3K | |
| 82952 | <1% | 1,812 | $3K | |
| 82947 | <1% | 3,358 | $3K | |
| 87186 | <1% | 1,302 | $3K | |
| 86430 | <1% | 1,893 | $3K | |
| 84460 | <1% | 861 | $2K | |
| 84450 | <1% | 851 | $2K | |
| 82565 | <1% | 1,783 | $2K | |
| 80076 | <1% | 1,144 | $2K | |
| 87088 | <1% | 1,003 | $2K | |
| 83550 | <1% | 937 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 179 | $2K |
| 82785 | <1% | 405 | $2K | |
| 86376 | <1% | 612 | $2K | |
| 84481 | <1% | 455 | $2K | |
| 86900 | <1% | 2,158 | $2K | |
| 86901 | <1% | 2,143 | $2K | |
| 86695 | <1% | 360 | $2K | |
| 84520 | <1% | 1,649 | $1K | |
| 80069 | <1% | 486 | $1K | |
| 86886 | <1% | 1,080 | $1K | |
| 82550 | <1% | 936 | $1K | |
| 82150 | <1% | 784 | $1K | |
| 86677 | <1% | 233 | $1K | |
| 83690 | <1% | 633 | $1K | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 76 | $1K |
| 82272 | <1% | 901 | $1K | |
| 82270 | <1% | 1,616 | $1K | |
| 84403 | <1% | 99 | $1K | |
| 86160 | <1% | 235 | $923.39 | |
| 83002 | <1% | 149 | $870.37 | |
| 86304 | <1% | 177 | $832.06 | |
| 85660 | <1% | 764 | $822.03 | |
| 86336 | <1% | 289 | $799.33 | |
| 86787 | <1% | 169 | $773.57 | |
| 86800 | <1% | 321 | $748.39 | |
| 86706 | <1% | 171 | $683.34 | |
| 84154 | <1% | 72 | $644.62 | |
| 86200 | <1% | 252 | $642.87 | |
| 83525 | <1% | 276 | $602.60 | |
| 82784 | <1% | 159 | $555.26 | |
| 86161 | <1% | 132 | $451.54 | |
| 82977 | <1% | 281 | $366.86 | |
| 86225 | <1% | 68 | $347.23 | |
| 82465 | <1% | 120 | $314.55 | |
| 82670 | <1% | 30 | $288.25 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 50 | $252.84 |
| 87181 | <1% | 262 | $221.76 | |
| 82248 | <1% | 152 | $213.20 | |
| 83615 | <1% | 172 | $193.50 | |
| 84478 | <1% | 53 | $164.70 | |
| 85044 | <1% | 246 | $155.16 | |
| 87338 | <1% | 53 | $109.19 | |
| 86235 | <1% | 17 | $108.37 | |
| 82042 | <1% | 61 | $101.35 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 12 | $101.04 |
| 85007 | <1% | 93 | $91.20 | |
| 84100 | <1% | 61 | $80.51 | |
| 80164 | <1% | 77 | $70.47 | |
| 82575 | <1% | 41 | $67.88 | |
| 86300 | <1% | 33 | $64.69 | |
| 84075 | <1% | 15 | $62.16 | |
| 86255 | <1% | 20 | $60.25 | |
| 83516 | <1% | 55 | $59.42 | |
| 82106 | <1% | 12 | $29.00 | |
| 87045 | <1% | 15 | $26.64 | |
| 83735 | <1% | 13 | $17.96 | |
| 86431 | <1% | 27 | $17.52 | |
| 83020 | <1% | 14 | $11.12 | |
| 85045 | <1% | 31 | $7.98 | |
| 3046F | 0% | 19 | $0.00 | |
| 82180 | 0% | 13 | $0.00 | |
| 3061F | 0% | 437 | $0.00 | |
| 3044F | 0% | 716 | $0.00 | |
| 3060F | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLOPEZ, SARA (PATHOLOGIST (DIRECTOR))
| Provider | Location | Paid |
|---|---|---|
| Laboratorio Clinico Y De Referencia De Fajardo, INC. | Fajardo, PR | $76K |
| Fajardo Integrated Medical Center | Fajardo, PR | $46K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.